CKG Goes to Campus: Skrining Gula Darah Puasa sebagai Upaya Deteksi Dini Diabetes Melitus pada Civitas Akademika Universitas Tarumanagara
DOI:
https://doi.org/10.69930/scitec.v3i3.852Keywords:
Deteksi Dini; Diabetes Melitus; Gula Darah Puasa; Pengabdian Kepada Masyarakat; SkriningAbstract
Diabetes melitus merupakan penyakit tidak menular dengan prevalensi yang terus meningkat dan sering kali tidak terdiagnosis pada tahap awal karena berlangsung tanpa gejala yang khas. Deteksi dini melalui pemeriksaan gula darah puasa berperan penting dalam mengidentifikasi gangguan regulasi glukosa sebelum berkembang menjadi komplikasi kronis. Kegiatan pengabdian kepada masyarakat ini bertujuan melaksanakan skrining gula darah puasa pada civitas akademika Universitas Tarumanagara melalui Program Cek Kesehatan Gratis (CKG) Goes to Campus sebagai upaya deteksi dini diabetes melitus. Kegiatan dilaksanakan menggunakan pendekatan Plan–Do–Check–Act (PDCA) yang meliputi tahap perencanaan, pemeriksaan gula darah puasa menggunakan metode point-of-care testing (POCT), evaluasi hasil pemeriksaan, serta tindak lanjut bagi peserta dengan hasil di luar nilai rujukan. Sebanyak 606 peserta mengikuti kegiatan skrining dengan rerata usia 29,55 ± 14,43 tahun. Rerata kadar gula darah puasa peserta adalah 97,98 ± 27,21 mg/dL. Sebagian besar peserta memiliki kadar gula darah puasa normal (72,1%), sedangkan 19,6% termasuk kategori prediabetes dan 8,3% mengarah pada diabetes melitus. Hasil tersebut menunjukkan bahwa lebih dari seperempat peserta telah mengalami gangguan regulasi glukosa meskipun sebagian besar berada pada usia produktif. Pelaksanaan skrining berbasis kampus terbukti efektif dalam mengidentifikasi individu yang berisiko mengalami diabetes melitus serta memperluas akses terhadap deteksi dini gangguan metabolisme glukosa. Program ini juga menghasilkan data epidemiologi awal yang dapat dimanfaatkan sebagai dasar pengembangan program kesehatan kampus berbasis promotif dan preventif serta mendorong tindak lanjut pemeriksaan di fasilitas pelayanan kesehatan bagi peserta dengan hasil abnormal.
Downloads
References
Albitres-Flores, L., Huayanay-Espinoza, C. A., Safary, E., Vetter, B., Cahuana-Hurtado, L., Lazo-Porras, M., & Bernabe-Ortiz, A. (2025). Implementation of multiparameter point-of-care testing devices for non-communicable diseases at primary healthcare level in Peru. BMC Health Services Research, 25(1), 1426. https://doi.org/10.1186/s12913-025-13554-3
Arnold, N., Greer, J., Peng, L., & Dudenbostel, T. (2025). Abstract FR506: Prevalence of prediabetes, associated clinical characteristics, and effects on blood pressure and arterial stiffness in young adults in a primary care setting. Hypertension, 82(Suppl. 1). https://doi.org/10.1161/HYP.82.SUPPL_1.FR506
Bennasar-Veny, M., Fresneda, S., López-González, A., Busquets-Cortés, C., Aguiló, A., & Yañez, A. M. (2020). Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes. Nutrients, 12(5), 1538. https://doi.org/10.3390/nu12051538
Dal Canto, E., Ceriello, A., Rydén, L., Ferrini, M., Hansen, T. B., Schnell, O., Standl, E., & Beulens, J. W. (2019). Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. European Journal of Preventive Cardiology, 26(2_suppl), 25–32. https://doi.org/10.1177/2047487319878371
Effah Nyarko, B., Amoah, R. S., & Crimi, A. (2019). Boosting diabetes and pre-diabetes detection in rural Ghana. F1000Research, 8, 289. https://doi.org/10.12688/f1000research.18497.2
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275
Genitsaridi, I., Salpea, P., Salim, A., Sajjadi, S. F., Tomic, D., James, S., Thirunavukkarasu, S., Issaka, A., Chen, L., Basit, A., Luk, A. O. Y., Ma, R. C. W., Mbanya, J.-C., Ramachandran, A., Wild, S. H., Duncan, B. B., Boyko, E. J., & Magliano, D. J. (2026). 11th edition of the IDF Diabetes Atlas: Global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. The Lancet Diabetes & Endocrinology, 14(2), 149–156. https://doi.org/10.1016/S2213-8587(25)00299-2
Hussain, A. (2025). Chronic hyperglycemia and cardiovascular dysfunction: An in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus. Cardiovascular Diabetology–Endocrinology Reports, 11, 39. https://doi.org/10.1186/s40842-025-00247-3
Kobayashi, E., Linden-Santangeli, N. J., Chan, N., Toomey, C. B., Mudaliar, S., Temprosa, M., Edelstein, S., Goyal, R., Rangamani, P., Majithia, A. R., Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., Chatellier, A., Dragg, A., Champagne, C. M., Duncan, C., Eberhardt, B., … Hivert, M.-F. (2025). Longitudinal metabolic trajectories in Diabetes Prevention Program participants reveal subgroups with varying micro- and macrovascular complication risks. Diabetes Care, 48(10), 1704–1712. https://doi.org/10.2337/dc25-0866
Liu, Y., Guo, H., Wang, Q., Lian, D., Yang, M., Huang, K., Chen, J., Xuan, Y., Zhang, J., Wei, Q., Fang, S., Xu, J., Liu, Y., Sun, K., Sun, Z., & Wang, B. (2019). Use of capillary glucose combined with other non-laboratory examinations to screen for diabetes and prediabetes. Diabetic Medicine, 36(12), 1671–1678. https://doi.org/10.1111/dme.14101
Mahat, R. K., Singh, N., Arora, M., & Rathore, V. (2019). Health risks and interventions in prediabetes: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(4), 2803–2811. https://doi.org/10.1016/j.dsx.2019.07.041
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025). Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications. International Journal of Molecular Sciences, 26(3), 1094. https://doi.org/10.3390/ijms26031094
Palladino, R., Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., & Vamos, E. P. (2020). Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes. BMJ Open Diabetes Research & Care, 8(1), e001061. https://doi.org/10.1136/bmjdrc-2019-001061
Schrems, E., Gruber, J. R., Schiweck, C., Ruf, A., Reif, A., Goldbach, R., Edwin Thanarajah, S., & Matura, S. (2025). Daily life stress is linked to increased glucose levels in individuals with insulin resistance: A real-world assessment. Diabetologia, 68(12), 2709–2718. https://doi.org/10.1007/s00125-025-06552-x
Wahidin, M., Achadi, A., Besral, B., Kosen, S., Nadjib, M., Nurwahyuni, A., Ronoatmodjo, S., Rahajeng, E., Pane, M., & Kusuma, D. (2024). Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs. Scientific Reports, 14(1), 5424. https://doi.org/10.1038/s41598-024-54563-2
Yahia, N., Brown, C. A., Snyder, E., Cumper, S., Langolf, A., Trayer, C., & Green, C. (2017). Prevalence of metabolic syndrome and its individual components among Midwestern university students. Journal of Community Health, 42(4), 674–687. https://doi.org/10.1007/s10900-016-0304-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Susy Olivia Lontoh, Alexander Halim Santoso, Fiona Valencia Setiawan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
